Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MabVax Therapeutics Holdings Inc (NASDAQ:MBVX)

0.6883
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
0.43
Today|||52-Week Range
4.25
-79.64%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$14.2M

Company Description

MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.

Contact Information

MabVax Therapeutics Holdings, Inc.
11535 Sorrento Valley Road
San Diego California 92121
P:(858) 259-9405
Investor Relations:

Employees

Shareholders

Other institutional12.92%
Individual stakeholders1.74%
Mutual fund holders0.04%

Top Executives

John David HansenChairman, President & Chief Executive Officer
Gregory P. HansonCFO & Principal Accounting Officer
Philip O. LivingstonDirector & Chief Science Officer
Wolfgang W. ScholzVice President-Antibody Discovery